The mechanism of GPCR involved in this cancer is the indirect activation of epidermal growth factor receptor (EGFR), by the release of epidermal growth factor (EGF) ligands from the surface which activates the intracellular signalling pathways [44]. The gene discussed is EGFR; the disease is cancer.